ČUNDRLE, Ivan, Virend K. SOMER, Bruce D. JOHNSON, Christopher G. SCOTT a Lyle J. OLSON. Exercise End-Tidal CO2 Predicts Central Sleep Apnea in Patients With Heart Failure. CHEST. Glenview: American College of Chest Physicians, 2015, roč. 147, č. 6, s. 1566-1573. ISSN 0012-3692. Dostupné z: https://dx.doi.org/10.1378/chest.14-2114.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Exercise End-Tidal CO2 Predicts Central Sleep Apnea in Patients With Heart Failure
Autoři ČUNDRLE, Ivan (203 Česká republika, garant, domácí), Virend K. SOMER (840 Spojené státy), Bruce D. JOHNSON (840 Spojené státy), Christopher G. SCOTT (840 Spojené státy) a Lyle J. OLSON (840 Spojené státy).
Vydání CHEST, Glenview, American College of Chest Physicians, 2015, 0012-3692.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 6.136
Kód RIV RIV/00216224:14110/15:00082715
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1378/chest.14-2114
UT WoS 000355837900037
Klíčová slova anglicky central sleep apnea; cardiopulmonary exercise testing; hypocapnea; chemosensitivity
Štítky EL OK
Příznaky Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 9. 11. 2015 12:05.
Anotace
BACKGROUND: Increased CO2 chemosensitivity and augmented exercise ventilation are characteristic of patients with heart failure (HF) with central sleep apnea (CSA). The aim of this study was to test the hypothesis that decreased end-tidal CO2 by cardiopulmonary exercise testing predicts CSA in patients with HF. METHODS: Consecutive ambulatory patients with New York Heart Association II to III HF were prospectively evaluated by CO2 chemosensitivity by rebreathe, cardiopulmonary exercise testing, and polysomnography (PSG). Subjects were classified as having either CSA (n = 20) or no sleep apnea (n = 13) by PSG; a central apnea-hypopnea index (AHI) >= 5 was used to define CSA. Subgroups were compared by t test or Mann-Whitney test and data summarized as mean +/- SD. P < .05 was considered significant. RESULTS: At rest, subjects with CSA had higher central CO2 chemosensitivity (Delta minute ventilation [(V) over dotE]/Delta partial pressure of end-tidal CO2 [PETCO2], 2.3 +/- 1.0 L/min/mm Hg vs 1.6 +/- 0.4 L/min/mm Hg, P = .02) and (V) over dotE (15 +/- 7 L/min vs 10 +/- 3 L/min, P = .02) and lower PETCO2 (31 +/- 4 mm Hg vs 35 +/- 4 mm Hg, P < .01) than control subjects. At peak exercise, the ventilatory equivalents per expired CO2 ((V) over dotE/(V) over dotCO(2)) was higher (43 +/- 9 vs 33 +/- 6, P < .01) and PETCO2 lower (29 +/- 6 mm Hg vs 36 +/- 5 mm Hg, P < .01) in subjects with CSA. In addition, CO2 chemosensitivity, peak exercise (V) over dotE/(V) over dotCO(2), and PETCO2 were independently correlated with CSA severity as quantified by the AHI (P < .05). Peak exercise PETCO2 was most strongly associated with CSA (OR, 1.29; 95% CI, 1.08-1.54; P = .01; area under the curve, 0.88). CONCLUSIONS: In patients with HF and CSA, ventilatory drive is increased while awake at rest and during exercise and associated with heightened CO2 chemosensitivity and decreased arterial CO2 set point.
VytisknoutZobrazeno: 4. 10. 2024 02:27